BUY MTAR Technologies — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))15 Apr 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·15 Apr · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on MTAR Technologies
- BUY — Rachit Khandelwal8 Sept 2026 · ~2 weeks · target ₹8,400 · Expired
- BUY — Shivangi Sarda, Motilal Oswal26 Aug 2026 · Same day · target ₹7,300 · Expired
- BUY — Motilal Oswal30 Jul 2026 · ~1 year · target ₹7,550 · Target hit
- BUY — Vaishali Parekh, Prabhudas Lilladher8 Jul 2026 · ~3 months · target ₹7,500 · SL hit
- BUY — Vikas Salunkhe, Nirmal Bang Securities12 Jun 2026 · ~2 weeks · target ₹7,800 · Target hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

